09:12 AM EDT, 10/04/2024 (MT Newswires) -- Health care stocks rose in pre-bell activity Friday as the Health Care Select Sector SPDR Fund ( XLV ) was 0.2% higher and the iShares Biotechnology ETF ( IBB ) up almost 1%.

Summit Therapeutics ( SMMT ) shares rose by over 11% after the company said it completed enrollment in its late-stage HARMONi clinical trial from North America, Europe, and China, with topline data expected in mid-2025.

Exact Sciences ( EXAS ) shares were over 2% higher after the company said the US Food and Drug Administration approved its Cologuard Plus multitarget stool DNA test.

Editas Medicine ( EDIT ) shares were up nearly 3% after the company said it has sold future license fees and other payments it is owned under a license agreement for its Cas9 gene-editing technology to a wholly-owned subsidiary of DRI Healthcare Trust for $57 million in cash.